Skip to search formSkip to main contentSkip to account menu

RG 7227

Known as: RG-7227, RG7227 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

danoprevir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Pharmacokinetics of a Three-Way Drug Interaction Between Danoprevir, Ritonavir and the Organic Anion Transporting Polypeptide (OATP) Inhibitor Ciclosporin
BackgroundDanoprevir (RG7227) is a potent macrocyclic inhibitor of the hepatitis C virus NS3/4A protease, which is currently in… 
2012
2012
Understanding the drug resistance mechanism of hepatitis C virus NS3/4A to ITMN-191 due to R155K, A156V, D168A/E mutations: a computational study.
2011
2011
Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients.
2011
2011
[Future perspective in the treatment of chronic hepatitis C].
The main lines of research into new drugs and treatment strategies against type C viral hepatitis are described. This disease is… 
2011
2011
Future perspectives in the treatment of chronic Hepatitis
The main lines of research into new drugs and treatment strategies against type C viral hepatitis are described. This disease is… 
2010
2010
753 IMPACT OF LOW DOSE RITONAVIR BOOSTING ON THE PHARMACOKINETICS OF RG7227 (ITMN-191), A HIGHLY POTENT AND SELECTIVE INHIBITOR OF THE HCV NS3/4A PROTEASE
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)